• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

MELANOMA

Immune checkpoint blockade in cancer immunotherapy

August 28, 2018Cancer, Cancer Immunotherapy, Vizit Graphs
Immune checkpoint blockade in cancer immunotherapy

Explore immune checkpoint blockade (PD-1, CTLA-4) in cancer immunotherapy with Biovista Vizit. Explore the live graph.

Vizit Graphs Tag Cloud

INFLAMMATION CTLA4 CANCER ERBB-2 ESCHERICHIA COLI IL23A LISTERIA MONOCYTOGENES PORPHYROMONAS GINGIVALIS RHEUMATOID ARTHRITIS SOD1 TH17 CELLS IMMUNE RESPONSE CELL DIVISION CELL DIFFERENTIATION 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE TP53 STREPTOCOCCUS PNEUMONIAE AGING DOXORUBICIN CASP3 DIABETES MELLITUS FOXP3 INSULIN APOPTOTIC PROCESS HELICOBACTER PYLORI TNF PARKINSON DISEASE REMICADE STAPHYLOCOCCUS AUREUS ANGIOGENESIS CELL PROLIFERATION IL17A AUTOPHAGY METFORMIN BREAST CANCER CELL DEATH CD4 RECEPTOR PSEUDOMONAS AERUGINOSA NEURODEGENERATIVE DISORDERS CANDIDA ALBICANS IFNG IL6 CLOSTRIDIUM DIFFICILE ALZHEIMER'S DISEASE

© 2020 Biovista Vizit All Rights Reserved.